150 related articles for article (PubMed ID: 11532466)
1. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate.
Perrotti M; Bahamondes L; Petta C; Castro S
Fertil Steril; 2001 Sep; 76(3):469-73. PubMed ID: 11532466
[TBL] [Abstract][Full Text] [Related]
2. Forearm bone density in users of Depo-Provera as a contraceptive method.
Bahamondes L; Perrotti M; Castro S; Faúndes D; Petta C; Bedone A
Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women.
Tharnprisarn W; Taneepanichskul S
Contraception; 2002 Aug; 66(2):101-3. PubMed ID: 12204782
[TBL] [Abstract][Full Text] [Related]
4. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health.
Petitti DB; Piaggio G; Mehta S; Cravioto MC; Meirik O
Obstet Gynecol; 2000 May; 95(5):736-44. PubMed ID: 10775740
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
Wanichsetakul P; Kamudhamas A; Watanaruangkovit P; Siripakarn Y; Visutakul P
Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
[TBL] [Abstract][Full Text] [Related]
8. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Sep; 56(3):153-5. PubMed ID: 9347205
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Jul; 56(1):1-3. PubMed ID: 9306024
[TBL] [Abstract][Full Text] [Related]
11. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
Virutamasen P; Wangsuphachart S; Reinprayoon D; Kriengsinyot R; Leepipatpaiboon S; Gua C
Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
[TBL] [Abstract][Full Text] [Related]
12. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
Viola AS; Castro S; Marchi NM; Bahamondes MV; Viola CF; Bahamondes L
Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P; Bottazzi M; Steel SA
Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
[TBL] [Abstract][Full Text] [Related]
14. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
Sanches L; Marchi NM; Castro S; Juliato CT; Villarroel M; Bahamondes L
Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception.
Beksinska ME; Kleinschmidt I; Smit JA; Farley TM
Contraception; 2007 Jun; 75(6):438-43. PubMed ID: 17519149
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.
Cromer BA; Bonny AE; Stager M; Lazebnik R; Rome E; Ziegler J; Camlin-Shingler K; Secic M
Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.
Clark MK; Sowers M; Levy B; Nichols S
Fertil Steril; 2006 Nov; 86(5):1466-74. PubMed ID: 16996507
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
[TBL] [Abstract][Full Text] [Related]
19. A prospective, controlled study of the effects of hormonal contraception on bone mineral density.
Berenson AB; Radecki CM; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2001 Oct; 98(4):576-82. PubMed ID: 11576570
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in women using depot medroxyprogesterone acetate for contraception.
Scholes D; Lacroix AZ; Ott SM; Ichikawa LE; Barlow WE
Obstet Gynecol; 1999 Feb; 93(2):233-8. PubMed ID: 9932562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
